logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
Showing 1 - 20 of 26 Items
Showing 1 - 20 of 26 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Commentary

Evolving crises and unprecedented need: Research on health in humanitarian settings must not be overlooked

Rao VB, Baker H, Coldiron M, Garone D, Rieux C,  et al.
2025-05-01 • Lancet Global Health
2025-05-01 • Lancet Global Health
Journal Article
|
Research

Diagnostic yield of urine lipoarabinomannan and sputum tuberculosis tests in people living with HIV: a systematic review and meta-analysis of individual participant data

Broger T, Koeppel L, Huerga H, Miller P, Gupta-Wright A,  et al.
2023-06-01 • Lancet Global Health
2023-06-01 • Lancet Global Health
BACKGROUND
Sputum is the most widely used sample to diagnose active tuberculosis, but many people living with HIV are unable to produce sputum. Urine, in contrast, is readily availab...
Journal Article
|
Research

Hepatitis C treatment program in Maputo, Mozambique, the challenge of genotypes and key populations: A 5-year retrospective analysis of routine programmatic data

Loarec A, Gutierrez AG, Muvale G, Couto AM, Nguyen AP,  et al.
2023-03-30 • Health Science Reports
2023-03-30 • Health Science Reports
BACKGROUND AND AIMS
Hepatitis C (HCV) programs face challenges, especially linked to key populations to achieve World Health Organization (WHO) goals of eliminating hepatitis. Médeci...
Journal Article
|
Research

Fixed dose combination drugs for cardiovascular disease in a prolonged humanitarian crisis in Lebanon: an implementation study

Ansbro É, Masri S, Prieto-Merino D, Willis R, Aoun Bahous S,  et al.
2023-01-25 • BMJ Open
2023-01-25 • BMJ Open
OBJECTIVES
This pre–post implementation study evaluated the introduction of fixed dose combination (FDC) medications for atherosclerotic cardiovascular disease (ASCVD) secondary prev...
Conference Material
|
Abstract

A digital portable tablet audiometry monitoring tool for patients with drug-resistant tuberculosis

Arago M, Mangue M, Cumbi N, Zamudio AG, Loarec A,  et al.
2021-05-20 • MSF Scientific Days International 2021: Innovation
2021-05-20 • MSF Scientific Days International 2021: Innovation
WHAT CHALLENGE OR OPPORTUNITY DID YOU TRY TO ADDRESS? WERE EXISTING SOLUTIONS NOT AVAILABLE OR NOT GOOD ENOUGH?
Ototoxicity is an unfortunate side-effect of second-line injectable dr...
Conference Material
|
Slide Presentation

Fixed dose combination drugs for cardiovascular disease in Lebanon

Ansbro E, Masri S, Prieto-Merino D, Bahous SA, Molfino L,  et al.
2022-05-11 • MSF Scientific Days International 2022
2022-05-11 • MSF Scientific Days International 2022
Journal Article
|
Research

HIV-associated Kaposi's sarcoma in Maputo, Mozambique: outcomes in a specialized treatment center, 2010-2015

Fardhdiani V, Molfino L, Zamudio AG, Manuel R, Luciano G,  et al.
2018-01-19 • Infectious Agents and Cancer
2018-01-19 • Infectious Agents and Cancer
Kaposi's sarcoma (KS) is a common HIV-associated malignancy associated with disability, pain and poor outcomes. The cornerstone of its treatment is antiretroviral therapy, but advanced d...
Journal Article
|
Research

Extremely Low Hepatitis C prevalence among HIV co-infected individuals in 4 countries in sub-Saharan Africa

Loarec A, Carnimeo V, Molfino L, Kizito W, Muyindike WR,  et al.
2018-11-16 • AIDS
2018-11-16 • AIDS
: A multicentric, retrospective case-series analysis (facility-based) in five sites across Kenya, Malawi, Mozambique, and Uganda screened HIV-positive adults for hepatitis C virus (HCV) ...
Journal Article
|
Research

Outcomes of AIDS-associated Kaposi sarcoma in Mozambique after treatment with pegylated liposomal doxorubicin

Coldiron ME, Gutierrez Zamudio AG, Manuel R, Luciano G, Rusch B,  et al.
2021-01-07 • Infectious Agents and Cancer
2021-01-07 • Infectious Agents and Cancer
BACKGROUND
Kaposi’s sarcoma (KS) is a common HIV-associated malignancy frequently associated with poor outcomes. It is the most frequently diagnosed cancer in major cities of Mozambi...
Journal Article
|
Research

Systematic, Point-of-Care Urine Lipoarabinomannan (Alere TB-LAM) Assay for Diagnosing Tuberculosis in Severely Immunocompromised HIV-Positive Ambulatory Patients

Huerga H, Cossa L, Manhiça I, Bastard M, Telnov A,  et al.
2020-03-05 • American Journal of Tropical Medicine and Hygiene
2020-03-05 • American Journal of Tropical Medicine and Hygiene
Point-of-care urine-lipoarabinomannan (LAM) Alere Determine TB-LAM assay has shown utility diagnosing tuberculosis (TB) in HIV-positive, severely immunocompromised, TB-symptomatic patien...
Conference Material
|
Poster

Levels of pre-treatment HIV drug resistance in rural and urban settings, Mozambique

Carnimeo V, Fuentes S J, Pulido Tarquino IA, Vaz D, Molfino L,  et al.
2019-05-20 • MSF Scientific Days International 2019: Research
2019-05-20 • MSF Scientific Days International 2019: Research
Conference Material
|
Poster

Integrated hepatitis B prevention in PMTCT program in Chamanculo maternity, Maputo, Mozambique

Antabak NT, Loarec A, Nguyen AP, Eliseo NDM, Molfino L,  et al.
2018-05-04 • MSF Scientific Days International 2018: Research
2018-05-04 • MSF Scientific Days International 2018: Research
Journal Article
|
Pre-Print

Early assessment of antiretroviral efficacy is critical to prevent the emergence of resistance mutations in HIV-tuberculosis coinfected patients: a substudy of the CARINEMO-ANRS12146 trial

Baudin E, Bhatt NB, Rouzioux C, Serafini M, Molfino L,  et al.
2019-02-08 • F1000Research
2019-02-08 • F1000Research
BACKGROUND
In the CARINEMO ANRS 12146 clinical trial, HIV-tuberculosis co-infected patients in Mozambique were randomized to nevirapine (NVP) or to efavirenz (EFV)-based antiretrovir...
Journal Article
|
Research

Diagnostic value of the urine lipoarabinomannan assay in HIV-positive, ambulatory patients with CD4 below 200 cells/μl in 2 low-resource settings: A prospective observational study.

Huerga H, Rucker SCM, Cossa L, Bastard M, Amoros I,  et al.
2019-04-30 • PLOS Medicine
2019-04-30 • PLOS Medicine
BACKGROUND:
Current guidelines recommend the use of the lateral flow urine lipoarabinomannan assay (LAM) in HIV-positive, ambulatory patients with signs and symptoms of tuberculosis...
Journal Article
|
Short Report

Treatment outcomes of patients switching from an injectable drug to bedaquiline during short standardized MDR-TB treatment in Mozambique

Bastard M, Molfino L, Mutaquiha C, Galindo MA, Zindoga P,  et al.
2019-03-11 • Clinical Infectious Diseases
2019-03-11 • Clinical Infectious Diseases
Bedaquiline was recommended by WHO as the preferred option in treatment of MDR-TB patients with long regimen. However, no recommendation was given for the short MDR-TB regimen. Data from...
Journal Article
|
Research

High burden of cryptococcal antigenemia and meningitis among patients presenting at an emergency department in Maputo, Mozambique

Deiss R, Loreti C, Gutierrez AG, Filipe E, Tatia M,  et al.
2021-04-26 • PLOS One
2021-04-26 • PLOS One
BACKGROUND
Cryptococcal meningitis is a leading cause of HIV-related mortality in sub-Saharan Africa, however, screening for cryptococcal antigenemia has not been universally impleme...
Conference Material
|
Slide Presentation

A digital portable tablet audiometry monitoring tool for patients with drug-resistant tuberculosis

Arago M, Mangue M, Cumbi N, Zamudio AG, Loarec A,  et al.
2021-05-20 • MSF Scientific Days International 2021: Innovation
2021-05-20 • MSF Scientific Days International 2021: Innovation
Journal Article
|
Research

High attrition among HIV-infected patients with advanced disease treated in an intermediary referral center in Maputo, Mozambique

Molfino L, Kumar AMV, Isaakidis P, Van der Bergh R, Khogali MA,  et al.
2014-04-08 • Global Health Action
2014-04-08 • Global Health Action
Background : In Mozambique, antiretroviral therapy (ART) scale-up has been successfully implemented. However, attrition in care remains a major programmatic challenge. In 2009, an interm...
Conference Material
|
Abstract

Fixed dose combination drugs for cardiovascular disease in Lebanon

Ansbro E, Masri S, Prieto-Merino D, Bahous SA, Molfino L,  et al.
2022-05-11 • MSF Scientific Days International 2022
2022-05-11 • MSF Scientific Days International 2022
INTRODUCTION
Cardiovascular disease (CVD) is the leading cause of death and disability globally, including in humanitarian contexts. Fixed-dose combination (FDC) drugs are cost-effec...
Journal Article
|
Research

I saw it as a second chance- a qualitative exploration of experiences of treatment failure and regimen change among people living with HIV on second- and third-line antiretroviral therapy in Kenya, Malawi and Mozambique

Burns R, Borges J, Blasco P, Vandenbulcke A, Mukui I,  et al.
2019-01-11 • Global Public Health
2019-01-11 • Global Public Health
Increasing numbers of people living with HIV (PLHIV) in sub-Saharan Africa are experiencing failure of first-line antiretroviral therapy and transitioning onto second-line regimens. Howe...